The DOI matches its Crossref record; 285 of the 285 references it cites were found in a registry or an index.
Metabolic targets for cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–285 of 285
Holen, K., Saltz, L. B., Hollywood, E., Burk, K., & Hanauske, A.-R. (2008) · Investigational New Drugs · doi:10.1007/s10637-007-9083-2 · Cited by 293
Holubarsch, C. J. F., Rohrbach, M., Karrasch, M., Boehm, E., Polonski, L., Ponikowski, P., & Rhein, S. (2007) · Clinical Science · doi:10.1042/cs20060307 · Cited by 287
Alavian, K. N., Li, H., Collis, L., Bonanni, L., Zeng, L., Sacchetti, S., Lazrove, E., Nabili, P., Flaherty, B., Graham, M., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2330 · Cited by 283
Targeting 6-Phosphofructo-2-Kinase (PFKFB3) as a Therapeutic Strategy against Cancer
Clem, B. F., O'Neal, J., Tapolsky, G., Clem, A. L., Imbert-Fernandez, Y., Kerr, D. A., Klarer, A. C., Redman, R., Miller, D. M., Trent, J. O., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0097 · Cited by 276
Martinez-Outschoorn, U. E., Lin, Z., Trimmer, C., Flomenberg, N., Wang, C., Pavlides, S., Pestell, R. G., Howell, A., Sotgia, F., & Lisanti, M. P. (2011) · Cell Cycle · doi:10.4161/cc.10.15.16585 · Cited by 270
Zhao, Y. H., Zhou, M., Liu, H., Ding, Y., Khong, H. T., Yu, D., Fodstad, O., & Tan, M. (2009) · Oncogene · doi:10.1038/onc.2009.229 · Cited by 269
A metabolic prosurvival role for PML in breast cancer
Carracedo, A., Weiss, D., Leliaert, A. K., Bhasin, M., de Boer, V. C. J., Laurent, G., Adams, A. C., Sundvall, M., Song, S. J., Ito, K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62129 · Cited by 269
mTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α
Cam, H., Easton, J. B., High, A., & Houghton, P. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.030 · Cited by 266
Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin
Min, L., Ji, Y., Bakiri, L., Qiu, Z., Cen, J., Chen, X., Chen, L., Scheuch, H., Zheng, H., Qin, L., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2590 · Cited by 246
Sheen, J.-H., Zoncu, R., Kim, D., & Sabatini, D. M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.012 · Cited by 239
Identification of small molecule inhibitors of pyruvate kinase M2
Vander Heiden, M. G., Christofk, H. R., Schuman, E., Subtelny, A. O., Sharfi, H., Harlow, E. E., Xian, J., & Cantley, L. C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.003 · Cited by 237
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
Goldberg, M. S., & Sharp, P. A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111487 · Cited by 230
Keller, K. E., Tan, I. S., & Lee, Y.-S. (2012) · Science · doi:10.1126/science.1224409 · Cited by 228
MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors
Birsoy, K., Wang, T., Possemato, R., Yilmaz, O. H., Koch, C. E., Chen, W. W., Hutchins, A. W., Gultekin, Y., Peterson, T. R., Carette, J. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2471 · Cited by 228
Myeloid-Derived Suppressor Cells in Human Cancer
Nagaraj, S., & Gabrilovich, D. I. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181eb3358 · Cited by 223
Fang, M., Shen, Z., Huang, S., Zhao, L., Chen, S., Mak, T. W., & Wang, X. (2010) · Cell · doi:10.1016/j.cell.2010.10.010 · Cited by 222
Howes, R. E., Battle, K. E., Satyagraha, A. W., Baird, J. K., & Hay, S. I. (2013) · Advances in Parasitology · doi:10.1016/b978-0-12-407826-0.00004-7 · Cited by 220
Methyl jasmonate binds to and detaches mitochondria-bound hexokinase
Goldin, N., Arzoine, L., Heyfets, A., Israelson, A., Zaslavsky, Z., Bravman, T., Bronner, V, Notcovich, A., Shoshan-Barmatz, V, & Flescher, E. (2008) · Oncogene · doi:10.1038/onc.2008.108 · Cited by 208
microRNA-451: A conditional switch controlling glioma cell proliferation and migration
Godlewski, J., Bronisz, A., Nowicki, M. O., Chiocca, E. A., & Lawler, S. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12248 · Cited by 203
Carducci, M. A., Gilbert, J., Bowling, M. K., Noe, D. A., Eisenberger, M. A., Sinibaldi, V. J., Zabelina, Y., Chen, T., Grochow, L. B., & Donehower, R. C. (2001) · PubMed · Cited by 202
Shen, Y.-C., Ou, D.-L., Hsu, C., Lin, K.-L., Chang, C.-Y., Lin, C.-Y., Liu, S.-H., & Cheng, A.-L. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.559 · Cited by 202
Fendt, S.-M., Bell, E. L., Keibler, M. A., Davidson, S. M., Wirth, G. J., Fiske, B., Mayers, J. R., Schwab, M., Bellinger, G., Csibi, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0080 · Cited by 199
Dwarakanath, B., Singh, D., Banerji, A., Sarin, R., Venkataramana, N., Jalali, R., Vishwanath, P., Mohanti, B., Tripathi, R., Kalia, V., et al. (2009) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.55136 · Cited by 194
Haigis, M. C., Deng, C.-X., Finley, L. W. S., Kim, H.-S., & Gius, D. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3633 · Cited by 194
Small molecule activation of PKM2 in cancer cells induces serine auxotrophy
Kung, C., Hixon, J., Choe, S., Marks, K., Gross, S., Murphy, E., DeLaBarre, B., Cianchetta, G., Sethumadhavan, S., Wang, X., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.07.021 · Cited by 192
Metabolism and proliferation share common regulatory pathways in cancer cells
Fritz, V, & Fajas, L. (2010) · Oncogene · doi:10.1038/onc.2010.182 · Cited by 192
Poff, A. M., Ari, C., Seyfried, T. N., & D’Agostino, D. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065522 · Cited by 191
The metabolic life and times of a T‐cell
Michalek, R. D., & Rathmell, J. C. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00911.x · Cited by 186
Cao, Z., Fan-Minogue, H., Bellovin, D. I., Yevtodiyenko, A., Arzeno, J., Yang, Q., Gambhir, S. S., & Felsher, D. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3367 · Cited by 178
Metabolic Profiling of Hypoxic Cells Revealed a Catabolic Signature Required for Cell Survival
Frezza, C., Zheng, L., Tennant, D. A., Papkovsky, D. B., Hedley, B. A., Kalna, G., Watson, D. G., & Gottlieb, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024411 · Cited by 177
Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth
Ghosh-Choudhury, N., Mandal, C. C., Ghosh-Choudhury, N., & Ghosh Choudhury, G. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.12.010 · Cited by 177
Sotgia, F., Martinez-Outschoorn, U. E., Pavlides, S., Howell, A., Pestell, R. G., & Lisanti, M. P. (2011) · Breast Cancer Research · doi:10.1186/bcr2892 · Cited by 177
Ras transformation requires metabolic control by 6-phosphofructo-2-kinase
Telang, S., Yalcin, A., Clem, A. L., Bucala, R., Lane, A. N., Eaton, J. W., & Chesney, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209709 · Cited by 168
Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice
Alli, P. M., Pinn, M. L., Jaffee, E. M., McFadden, J. M., & Kuhajda, F. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208174 · Cited by 167
Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status
Nishihara, R., Lochhead, P., Kuchiba, A., Jung, S., Yamauchi, M., Liao, X., Imamura, Y., Qian, Z. R., Morikawa, T., Wang, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6599 · Cited by 166
Chang, S. M., Kuhn, J. G., Rizzo, J., Robins, H. I., Schold, S. C., Spence, A. M., Berger, M. S., Mehta, M. P., Bozik, M. E., Pollack, I., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2188 · Cited by 166
Sharma, L. K., Fang, H., Liu, J., Vartak, R. S., Deng, J., & Bai, Y. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr395 · Cited by 164
Leonardi, R., Subramanian, C., Jackowski, S., & Rock, C. O. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.c112.353946 · Cited by 163
Schneiderhan, W., Scheler, M., Holzmann, K.-H., Marx, M., Gschwend, J. E., Bucholz, M., Gress, T. M., Seufferlein, T., Adler, G., & Oswald, F. (2009) · Gut · doi:10.1136/gut.2009.181412 · Cited by 161
Yang, T.-S., Lu, S.-N., Chao, Y., Sheen, I.-S., Lin, C.-C., Wang, T.-E., Chen, S.-C., Wang, J.-H., Liao, L.-Y., Thomson, J. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605856 · Cited by 159
M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth
Cortés-Cros, M., Hemmerlin, C., Ferretti, S., Zhang, J., Gounarides, J. S., Yin, H., Muller, A., Haberkorn, A., Chene, P., Sellers, W. R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212780110 · Cited by 159
The B55α Subunit of PP2A Drives a p53-Dependent Metabolic Adaptation to Glutamine Deprivation
Reid, M. A., Wang, W.-I., Rosales, K. R., Welliver, M. X., Pan, M., & Kong, M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.008 · Cited by 154
p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200
Morselli, E., Shen, S., Ruckenstuhl, C., Bauer, M. A., Mariño, G., Galluzzi, L., Criollo, A., Michaud, M., Maiuri, M. C., Chano, T., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.16.16868 · Cited by 154
Self-citation3-bromopyruvate: Targets and outcomes
Shoshan, M. C. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9419-2 · Cited by 148
Seguin, F., Carvalho, M. A., Bastos, D., Agostini, M., Zecchin, K. G., Alvarez-Flores, M. P., Chudzinski-Tavassi, A., Coletta, R. D., & Graner, E. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.355 · Cited by 148
Kuo, W.-Y., Lin, J.-Y., & Tang, T. K. (2000) · International Journal of Cancer · Cited by 146
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
Ott, P. A., Carvajal, R. D., Pandit-Taskar, N., Jungbluth, A. A., Hoffman, E. W., Wu, B.-W., Bomalaski, J. S., Venhaus, R., Pan, L., Old, L. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9862-2 · Cited by 146
Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
Bajrami, I., Kigozi, A., Van Weverwijk, A., Brough, R., Frankum, J., Lord, C. J., & Ashworth, A. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201250 · Cited by 136
Chiavarina, B., Whitaker‐Menezes, D., Martinez‐Outschoorn, U., Witkiewicz, A. K., Birbe, R., Howell, A., Pestell, R. G., Smith, J. A., Daniel, R., Sotgia, F., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.12.18703 · Cited by 130
Non‐apoptotic functions of apoptosis‐regulatory proteins
Galluzzi, L., Kepp, O., Trojel‐Hansen, C., & Kroemer, G. (2012) · The EMBO Reports · doi:10.1038/embor.2012.19 · Cited by 109
Self-citationSilybin and dehydrosilybin decrease glucose uptake by inhibiting GLUT proteins
Zhan, T., Digel, M., Kuech, E., Stremmel, W., & Füllekrug, J. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22984 · Cited by 109
Phenformin as prophylaxis and therapy in breast cancer xenografts
Appleyard, M. V. C. L., Murray, K. E., Coates, P. J., Wullschleger, S., Bray, S. E., Kernohan, N. M., Fleming, S., Alessi, D. R., & Thompson, A. M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.56 · Cited by 108
Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling
Yalçın, A., Clem, B. F., Makoni, S. N., Clem, A. L., Nelson, K. K., Thornburg, J. M., Siow, D. L., Lane, A. N., Brock, S. E., Goswami, U., et al. (2009) · Oncogene · doi:10.1038/onc.2009.317 · Cited by 98
Hao, J., Madigan, M. C., Khatri, A., Power, C. A., Hung, T., Beretov, J., Chang, L., Xiao, W., Cozzi, P. J., Graham, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040716 · Cited by 83
Talbot, D. C., von Pawel, J., Cattell, E., Yule, S. M., Johnston, C., Zandvliet, A. S., Huitema, A. D. R., Norbury, C. J., Ellis, P., Bosquée, L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0249 · Cited by 83
Camacho, L. H., Olson, J., Tong, W. P., Young, C. W., Spriggs, D. R., & Malkin, M. G. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-9017-4 · Cited by 81
Tandon, P., Gallo, C. A., Khatri, S., Barger, J. F., Yepiskoposyan, H., & Plas, D. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013629108 · Cited by 77
Clem, B. F., Clem, A. L., Yalçın, A., Goswami, U., Arumugam, S., Telang, S., Trent, J. O., & Chesney, J. A. (2011) · Oncogene · doi:10.1038/onc.2011.51 · Cited by 71
Normal and cancer cell metabolism: lymphocytes and lymphoma
Altman, B. J., & Dang, C. V. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08651.x · Cited by 68
Kumar, A., Kant, S., & Singh, S. M. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.06.005 · Cited by 66
Haddad, R. I., Weinstein, L. J., Wieczorek, T. J., Bhattacharya, N., Raftopoulos, H., Oster, M. W., Zhang, X., Latham, V. M., Costello, R., Faucher, J., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0229 · Cited by 66
Bonovas, S., Nikolopoulos, G. K., & Bagos, P. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045259 · Cited by 64
Lethal weapons: DAP-kinase, autophagy and cell death
Bialik, S., & Kimchi, A. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.11.004 · Cited by 63
Chang, S. M., Kuhn, J. G., Robins, H. I., Schold, S. C., Spence, A. M., Berger, M. S., Mehta, M. P., Bozik, M. E., Pollack, I., Schiff, D., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.984 · Cited by 61
Phase II study of E7070 in patients with metastatic melanoma
Smyth, J. F., Aamdal, S., Awada, A. H., Dittrich, C., Caponigro, F., Schöffski, P., Gore, M. E., Lesimple, T., Djurasinovic, N., Barón, B., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdi016 · Cited by 59
Yuan, H., Lu, J., Xiao, J., Upadhyay, G., Umans, R., Kallakury, B., Yin, Y., Fant, M. E., Kopelovich, L., & Glazer, R. I. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0322 · Cited by 56
The Effect of Arginase on the Retardation of Tumour Growth
Bach, S. J., & Swaine, D. (1965) · British Journal of Cancer · doi:10.1038/bjc.1965.45 · Cited by 55
Mor, I., Carlessi, R., Ast, T., Feinstein, E., & Kimchi, A. (2011) · Oncogene · doi:10.1038/onc.2011.264 · Cited by 54
Owens, K. M., Aykin‐Burns, N., Dayal, D., Coleman, M. C., Domann, F. E., & Spitz, D. R. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.435 · Cited by 53
Strum, S. B., Adalsteinsson, Ö., Black, R. R., Segal, D., Peress, N. L., & Waldenfels, J. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9496-2 · Cited by 51
Ousset, M., Bouquet, F., Fallone, F., Biard, D. S. F., Dray, C., Valet, P., Salles, B., & Muller, C. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12253 · Cited by 51
Yuan, W., Wu, S., Guo, J., Chen, Z., Ge, J., Yang, P., Hu, B., & Chen, Z. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.9.11431 · Cited by 50
Proliferation-Independent Control of Tumor Glycolysis by PDGFR-Mediated AKT Activation
Ran, C., Liu, H., Hitoshi, Y., & Israel, M. A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2460 · Cited by 50
Ma, L., Niknejad, N., Gorn‐Hondermann, I., Dayekh, K., & Dimitroulakos, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046055 · Cited by 47
Results from a phase I, dose-escalation study of PX-478, an orally available inhibitor of HIF-1α.
Tibes, R., Falchook, G. S., Von Hoff, D. D., Weiss, G. J., Iyengar, T., Kurzrock, R., Pestano, L., Lowe, A. M., & Herbst, R. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.3076 · Cited by 46
Gautier, E. L., Westerterp, M., Bhagwat, N., Cremers, S., Shih, A. H., Abdel-Wahab, O. I., Lütjohann, D., Randolph, G. J., Levine, R. L., Tall, A. R., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121357 · Cited by 45
Okumura, S., Sasaki, T., Minami, Y., & Ohsaki, Y. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318233d686 · Cited by 44
Methyljasmonate displays in vitro and in vivo activity against multiple myeloma cells
Klippel, S., Jakubı́ková, J., Delmore, J. E., Ooi, M. G. M., McMillin, D. W., Kastritis, E., Laubach, J. P., Richardson, P. G. G., Anderson, K. C., & Mitsiades, C. S. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09253.x · Cited by 30
Andela, V. B., Altuwaijri, S., Wood, J., & Rosier, R. N. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.082 · Cited by 29
Watanabe, M., Abe, N., Oshikiri, Y., Stanbridge, E. J., & Kitagawa, T. (2012) · Oncogenesis · doi:10.1038/oncsis.2012.21 · Cited by 27
Cocco, P., Dessı̀, S., Avataneo, G., Picchiri, G., & Heinemann, E. (1989) · Carcinogenesis · doi:10.1093/carcin/10.5.813 · Cited by 24
Anisimov, V. N., Berstein, L. M., Popovich, I. G., Zabezhinski, M. A., Egormin, P. A., Тындык, М. Л., Anikin, I. V., Semenchenko, A. V., & Yashin, A. I. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1356.017 · Cited by 18
Glucose-6-Phosphate Dehydrogenase Deficiency and Lung Cancer: A Hospital Based Case-Control Study
Pisano, M., Cocco, P., Cherchi, R., Onnis, R., & Cherchi, P. (1991) · Tumori Journal · doi:10.1177/030089169107700103 · Cited by 17
Can Fasting Blunt Chemotherapy's Debilitating Side Effects?
Couzin, J. (2008) · Science · doi:10.1126/science.321.5893.1146a · Cited by 16
Garber, A. J. (1997) · Endocrine Practice · doi:10.4158/ep.3.6.359 · Cited by 15
Cited by
Macrophages and metabolism in the tumor microenvironment
Vitale, I., Manic, G., Coussens, L. M., Kroemer, G., & Galluzzi, L. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.001 · Cited by 1,837
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
Acetyl coenzyme A: a central metabolite and second messenger
Pietrocola, F., Galluzzi, L., Bravo-San Pedro, J. M., Madeo, F., & Kroemer, G. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.014 · Cited by 1,378
Self-citationMitochondrial metabolism and cancer
Porporato, P. E., Filigheddu, N., Pedro, J. M. B.-S., Kroemer, G., & Galluzzi, L. (2018) · Cell Research · doi:10.1038/cr.2017.155 · Cited by 1,273
Self-citationAutophagy in malignant transformation and cancer progression
Galluzzi, L., Pietrocola, F., Bravo‐San Pedro, J. M., Amaravadi, R. K., Baehrecke, E. H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D. A., Karantza, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490784 · Cited by 1,182
Self-citation
Metadata
- Authors
- Galluzzi, L., Kepp, O., Heiden, M. G. V., & Kroemer, G.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-10-11
- Volume
- 12
- Issue
- 11
- Pages
- 829-846
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2143036691
- Cited by
- 711
- References
- 285
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.